Test Bank - Pharmacology: A Patient-Centered Nursing
Process Approach (9th Edition) PHARMACOLOGY 9TH
EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 27: Antituberculars,
Chapter 01: Drug Development Antifungals, and Antivirals
and Ethical Considerations
Chapter 02:
Pharmacokinetics,
Pharmacodynamics, and
Pharmacogenetics
Chapter 03: Cultural
Considerations Chapter 04:
Complementary and
Alternative Therapies
Chapter 05: Pediatric
Considerations Chapter 06:
Geriatric Considerations
Chapter 07: Drugs in Substance
Use Disorder
Chapter 08: The Nursing Process
and Patient-Centered Care
Chapter 09: Safety and
Quality Chapter 10: Drug
Administration Chapter 11:
Drug Calculations Chapter
12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and
Mineral Replacement
Chapter 14: Nutritional Support
Chapter 15: Adrenergic Agonists
and Antagonists
Chapter 16: Cholinergic Agonists
and Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants
Chapter 19: Antiseizure
Drugs
Chapter 20: Drugs for
Parkinsonism and Alzheimer's
Disease
Chapter 21: Drugs for
Neuromuscular Disorders and
Muscle Spasms Chapter 22:
Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and
Mood Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
,Chapter 28: Peptides,
Antimalarial, and Anthelmintic
Chapter 29: HIV- and AIDS-
Related Drugs
Chapter 30: Transplant
Drugs Chapter 31:
Vaccines Chapter 32:
Anticancer Drugs
Chapter 33: Targeted Therapies to
Treat Cancer
Chapter 34: Biologic
Response Modifiers
Chapter 35: Upper
Respiratory Disorders
Chapter 36: Lower
Respiratory Disorders
Chapter 37: Cardiac
Glycosides, Antianginals,
and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and
Thrombolytics Chapter 41:
Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42:
Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear
Disorders Chapter 45:
Dermatologic Disorders
Chapter 46: Pituitary,
Thyroid, Parathyroid, and
Adrenal Disorders Chapter
47: Antidiabetics
Chapter 48: Urinary
Disorders Chapter 49:
Pregnancy and Preterm
Labor
Chapter 50: Labor,
Delivery, and Postpartum
Chapter 51: Neonatal and
Newborn Chapter 52:
Women's Reproductive
Health
Chapter 53: Men's
Reproductive Health Chapter
54: Sexually Transmitted
Infections
Chapter 55: Adult and
Pediatric Emergency
Drugs
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is
drawing up half of the contents of a Single-use vial. Which nursing action is
correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked
collection box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for.
When wasting a portion of a drug, another nurse should observe and cosign that
a drug was wasted.
DIF: COGNITIVE LEVEL: Applying
(Application) TOP: NURSING PROCESS:
Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available
in a generic form. The nurse understands that a generic medication will have a
name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS:
D
The generic name is the official, non-proprietary name for a drug. The brand name
is the trademark name and is always capitalized. The chemical name describes the
chemical structure of the drug.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a
generic medicationmay be given.The patient asks the nurse what this means.
What will the nurse tell the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are
marketed. ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to
the brand- name drug. They tend to be less expensive because manufacturers of
these drugs do not have to do the extensive testing required of brand-name drugs
before marketing. They are not identical to brand-name drugs and often have
different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient
Teaching MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the
drugs official name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety
standards. ANS: D
The USP designation is given to drugs that have met high standards for therapeutic
use, patient safety, quality, purity, strength, packaging safety, and dosage form by
the United States Pharmacopoeia National Formulary. The FDA classifies controlled
substances with Roman numerals from I to V. The USP designation does not indicate
FDA approval. The USP designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks
whether the drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights
compared to adult weights.
b. Drugs are deemed safe for children over time when repeated use proves
effectiveness and safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed
for pediatric use.
d. Drugs are tested on children in post marketing studies and on a
limited basis. ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs
on children. DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances
Act ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The
other acts govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
7. The nurse administers a drug and miscalculates the dose by placing the
decimal place one space to the right, resulting in a 10-fold overdose and the
death of the patient. What offense does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasanc
e ANS: C
Misfeasance is negligence in giving either the wrong drug or the wrong dose,
resulting in the death of the patient.
Process Approach (9th Edition) PHARMACOLOGY 9TH
EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 27: Antituberculars,
Chapter 01: Drug Development Antifungals, and Antivirals
and Ethical Considerations
Chapter 02:
Pharmacokinetics,
Pharmacodynamics, and
Pharmacogenetics
Chapter 03: Cultural
Considerations Chapter 04:
Complementary and
Alternative Therapies
Chapter 05: Pediatric
Considerations Chapter 06:
Geriatric Considerations
Chapter 07: Drugs in Substance
Use Disorder
Chapter 08: The Nursing Process
and Patient-Centered Care
Chapter 09: Safety and
Quality Chapter 10: Drug
Administration Chapter 11:
Drug Calculations Chapter
12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and
Mineral Replacement
Chapter 14: Nutritional Support
Chapter 15: Adrenergic Agonists
and Antagonists
Chapter 16: Cholinergic Agonists
and Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants
Chapter 19: Antiseizure
Drugs
Chapter 20: Drugs for
Parkinsonism and Alzheimer's
Disease
Chapter 21: Drugs for
Neuromuscular Disorders and
Muscle Spasms Chapter 22:
Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and
Mood Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
,Chapter 28: Peptides,
Antimalarial, and Anthelmintic
Chapter 29: HIV- and AIDS-
Related Drugs
Chapter 30: Transplant
Drugs Chapter 31:
Vaccines Chapter 32:
Anticancer Drugs
Chapter 33: Targeted Therapies to
Treat Cancer
Chapter 34: Biologic
Response Modifiers
Chapter 35: Upper
Respiratory Disorders
Chapter 36: Lower
Respiratory Disorders
Chapter 37: Cardiac
Glycosides, Antianginals,
and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and
Thrombolytics Chapter 41:
Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42:
Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear
Disorders Chapter 45:
Dermatologic Disorders
Chapter 46: Pituitary,
Thyroid, Parathyroid, and
Adrenal Disorders Chapter
47: Antidiabetics
Chapter 48: Urinary
Disorders Chapter 49:
Pregnancy and Preterm
Labor
Chapter 50: Labor,
Delivery, and Postpartum
Chapter 51: Neonatal and
Newborn Chapter 52:
Women's Reproductive
Health
Chapter 53: Men's
Reproductive Health Chapter
54: Sexually Transmitted
Infections
Chapter 55: Adult and
Pediatric Emergency
Drugs
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is
drawing up half of the contents of a Single-use vial. Which nursing action is
correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked
collection box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for.
When wasting a portion of a drug, another nurse should observe and cosign that
a drug was wasted.
DIF: COGNITIVE LEVEL: Applying
(Application) TOP: NURSING PROCESS:
Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available
in a generic form. The nurse understands that a generic medication will have a
name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS:
D
The generic name is the official, non-proprietary name for a drug. The brand name
is the trademark name and is always capitalized. The chemical name describes the
chemical structure of the drug.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a
generic medicationmay be given.The patient asks the nurse what this means.
What will the nurse tell the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are
marketed. ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to
the brand- name drug. They tend to be less expensive because manufacturers of
these drugs do not have to do the extensive testing required of brand-name drugs
before marketing. They are not identical to brand-name drugs and often have
different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient
Teaching MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the
drugs official name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety
standards. ANS: D
The USP designation is given to drugs that have met high standards for therapeutic
use, patient safety, quality, purity, strength, packaging safety, and dosage form by
the United States Pharmacopoeia National Formulary. The FDA classifies controlled
substances with Roman numerals from I to V. The USP designation does not indicate
FDA approval. The USP designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks
whether the drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights
compared to adult weights.
b. Drugs are deemed safe for children over time when repeated use proves
effectiveness and safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed
for pediatric use.
d. Drugs are tested on children in post marketing studies and on a
limited basis. ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs
on children. DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances
Act ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The
other acts govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
7. The nurse administers a drug and miscalculates the dose by placing the
decimal place one space to the right, resulting in a 10-fold overdose and the
death of the patient. What offense does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasanc
e ANS: C
Misfeasance is negligence in giving either the wrong drug or the wrong dose,
resulting in the death of the patient.
